Company / Depreciation & Amortization
Tango Therapeutics, Inc. Depreciation & Amortization History
FY2020-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$897.0K
FY2022
5-year range
$718.0K / $897.0K
FY2020-FY2022
Trend
+24.9%
vs FY2021
Sector context
#128 of 168
Health Care
What the data says
Tango Therapeutics, Inc.'s depreciation & amortization of $897,000 is lower than 76% of companies in the Health Care sector (FY2022). Increased from $718,000 to $897,000 over the past 2 years.
Based on SEC 10-K filings.
$897,000 in FY2022.
Increased from $718,000 to $897,000 over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 168This company $897.0K Sector average $212.9M
▼
-99.6% below sector average
Key checks
Key Insights
- In FY2022, depreciation & amortization increased 24.9% year-over-year.
- Ranks #128 out of 168 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $897.0K | +24.9% |
| FY2021 | $718.0K | +0.0% |
| FY2020 | $718.0K | - |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026